Evidence map›Paper›PMID 40564471›Full record

ArticleBioengineering (Basel, Switzerland)2025

AI-Powered Spectral Imaging for Virtual Pathology Staining.

Adam Soker, Maya Almagor, Sabine Mai, Yuval Garini

Abstract read
In one paragraph

Article in Bioengineering (Basel, Switzerland), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Review
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Adam SokerBiomedical Engineering Faculty & Russell Berrie Nanotechnology Institute, Technion-Israel Institute of Technology, Haifa 3200003, Israel.ORCID 0009-0009-8633-3212
Maya AlmagorBiomedical Engineering Faculty & Russell Berrie Nanotechnology Institute, Technion-Israel Institute of Technology, Haifa 3200003, Israel.ORCID 0009-0003-4457-7856
Sabine MaiDepartment of Physiology and Pathophysiology, University of Manitoba, Winnipeg, MB R3T 2N2, Canada.ORCID 0000-0002-5797-2201
Yuval GariniBiomedical Engineering Faculty & Russell Berrie Nanotechnology Institute, Technion-Israel Institute of Technology, Haifa 3200003, Israel.ORCID 0000-0002-8783-2015

Funding

European ATTRACT program HipMed-2022Israel Science Foundation 2019/17Zimin Institute 2024
6 · The paper itself

Abstract

Pathological analysis of tissue biopsies remains the gold standard for diagnosing cancer and other diseases. However, this is a time-intensive process that demands extensive training and expertise. Despite its importance, it is often subjective and not entirely error-free. Over the past decade, pathology has undergone two major transformations. First, the rise in whole slide imaging has enabled work in front of a computer screen and the integration of image processing tools to enhance diagnostics. Second, the rapid evolution of Artificial Intelligence has revolutionized numerous fields and has had a remarkable impact on humanity. The synergy of these two has paved the way for groundbreaking research aiming for advancements in digital pathology. Despite encouraging research outcomes, AI-based tools have yet to be actively incorporated into therapeutic protocols. This is primary due to the need for high reliability in medical therapy, necessitating a new approach that ensures greater robustness. Another approach for improving pathological diagnosis involves advanced optical methods such as spectral imaging, which reveals information from the tissue that is beyond human vision. We have recently developed a unique rapid spectral imaging system capable of scanning pathological slides, delivering a wealth of critical diagnostic information. Here, we present a novel application of spectral imaging (SI) for virtual Hematoxylin and Eosin (H&E) staining using a custom-built, rapid Fourier-based SI system. Unstained human biopsy samples are scanned, and a Pix2Pix-based neural network generates realistic H&E-equivalent images. Additionally, we applied Principal Component Analysis (PCA) to the spectral information to examine the effect of down sampling the data on the virtual staining process. To assess model performance, we trained and tested models using full spectral data, RGB, and PCA-reduced spectral inputs. The results demonstrate that PCA-reduced data preserved essential image features while enhancing statistical image quality, as indicated by FID and KID scores, and reducing computational complexity. These findings highlight the potential of integrating SI and AI to enable efficient, accurate, and stain-free digital pathology.

Indexed as

artificial intelligence in medicinedigital pathologyspectral imagingvirtual staining

Identifiers

PMID40564471
PMCPMC12189724

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.